AbCellera Biologics Inc.

NASDAQ: ABCL · Real-Time Price · USD
4.58
0.08 (1.78%)
At close: Aug 15, 2025, 3:59 PM
4.59
0.22%
After-hours: Aug 15, 2025, 07:59 PM EDT

AbCellera Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-162.86M -146.4M 158.52M 153.46M
Depreciation & Amortization
97M 30.89M 33.1M 17.25M
Stock-Based Compensation
67.58M 64.18M 49.48M 30.65M
Other Working Capital
n/a 56.01M 51.47M 36.74M
Other Non-Cash Items
-84.44M -7.74M 8.55M 3.57M
Deferred Income Tax
n/a 1.96M -2.11M -2.02M
Change in Working Capital
-25.84M 13.22M 29.82M 41.67M
Operating Cash Flow
-108.56M -43.88M 277.36M 244.58M
Capital Expenditures
-78.4M -77.51M -72.66M -58.45M
Cash Acquisitions
-19.63M -13.69M -25.68M -41.78M
Purchase of Investments
-765.09M -1.07B -781.35M -292.24M
Sales Maturities Of Investments
948.81M 910.94M 510.63M 27.61M
Other Investing Acitivies
35.71M 25.31M 16.43M 32.62M
Investing Cash Flow
121.41M -221.11M -352.63M -332.25M
Debt Repayment
n/a 11.59M 2.75M 5.49M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
12.77M -1.23M -4.38M -9.37M
Financial Cash Flow
12.77M 10.36M -1.63M -3.89M
Net Cash Flow
23M -254.04M -86.49M -92.97M
Free Cash Flow
-186.95M -121.38M 204.7M 186.13M